The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison (Q59651031)
Jump to navigation
Jump to search
scientific article published in The Lancet
Language | Label | Description | Also known as |
---|---|---|---|
English | The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison |
scientific article published in The Lancet |
Statements
The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison (English)
David G Sherman
Gregory W Albers
Christopher Bladin
Cesare Fieschi
Alberto A Gabbai
William O'Riordan
Graham F Pineo
PREVAIL Investigators